C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/06 (2006.01) A61K 31/495 (2006.01) A61P 3/00 (2006.01) A61P 9/00 (2006.01) C07D 473/04 (2006.01)
Patent
CA 2618963
The present invention relates to compounds 0f formula (I), which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
La présente invention concerne des composés de formule (I) qui constituent des dérivés de xanthine, des procédés de fabrication desdits dérivés, des préparations pharmaceutiques contenant les composés actifs et l'utilisation desdits composés en thérapie, par exemple, dans le traitement de maladies, au cours desquelles la sous-activation du récepteur HM74A favorise la maladie ou bien l'activation du récepteur est bénéfique.
Hatley Richard Jonathan Daniel
Heer Jag Paul
Liddle John
Mason Andrew Mcmurtrie
Pinto Ivan Leo
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Xanthine derivatives as selective hm74a agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives as selective hm74a agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives as selective hm74a agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1648860